Search reports, ask a question, or jump to a page.
The problem
Intervention: I-ACQUIRE therapy, a multicomponent form of Constraint-Induced Movement Therapy involving intensive practice (moderate-dose: 3 hours/day, 5 days/week for 4 weeks; high-dose: 6 hours/day) with substantial parent participation
Who it was tested with: Infants and toddlers with perinatal arterial ischemic stroke and hemiparesis (n=167 parent-child dyads: 56 moderate-dose, 58 high-dose, 53 usual treatment).
Experience from people who deliver programmes: stories, case studies and lessons learned. Valuable for understanding how and why, and for spotting what to test next, but not a measure of effect.
"Parents completed assessments about life- and therapy-related stress, treatment concerns, observations of child progress, and perceived therapy-related responsibilities." This prospective measurement of parent perspectives across randomly assigned treatment groups provides systematic evidence of how parents experience different treatment intensities, complementing clinical outcome data.
The study measures parent perceptions and satisfaction rather than objective child outcomes. Parents were not blinded to treatment assignment. The findings show parental experience but cannot directly establish whether I-ACQUIRE produces better functional gains than usual treatment.
Across countries and designs
1 study · 1 country
